We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
REAGILA (Gedeon Richter Australia Pty Ltd)
Product name
REAGILA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
196 working days (255)
Active ingredients
cariprazine hydrochloride
Registration type
NCE/NBE
Indication
REAGILA (hard capsule) is indicated for the treatment of schizophrenia in adult patients.